Company intelligence / Profile preview

Bebevida

Porto, Porto, Portugal

Ownership: Private
Employees: ~40
Development stage: Other

Overview

Bebé Vida is a Portuguese healthcare company specializing in the cryopreservation of stem cells from umbilical cord blood and tissue. Established in 2004, it operates as a private family bank, offering services for the collection, processing, and long-term storage of newborn stem cells. The company is licensed by the Portuguese health authorities and maintains state-of-the-art laboratory facilities to support potential future applications in regenerative medicine and the treatment of blood-related disorders. Bebé Vida also provides prenatal screening services and educational resources for expectant parents.

Therapeutic areas: OncologyImmunologyHematologyMetabolic Disorders
Modalities: Cell therapyStem cell therapy
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Bebevida.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bebevida.

Explore the full profile